Dr. Jasmer is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1750 El Camino Real
Ste 307
Burlingame, CA 94010Phone+1 650-697-7079- Is this information wrong?
Summary
- Dr. Robert Jasmer is a pulmonologist in Burlingame, CA and is affiliated with Mills-Peninsula Health Servicel. He graduated with honors from Harvard University and then again with honors from Washington University School of Medicine. He did his internal medicine internship and residency at Stanford University Medical Center, then spent an additional year as the Chief Medical Resident at Stanford, followed by fellowship in Pulmonary Diseases and Critical Care Medicine at the University of California, San Francisco (UCSF). He then joined the faculty at UCSF in 1997 and was an Associate Professor of Medicine. Dr. Jasmer's clinical and research interests include interstitial lung disease, pulmonary hypertension, sepsis, respiratory infections, chronic obstructive pulmonary disease (COPD), asthma, pulmonary complications of HIV infection, tuberculosis, and critical care medicine. He has published over 40 peer-reviewed scientific articles and chapters on these topics and is a nationally recognized expert in tuberculosis. In 2006, Dr Jasmer went into full-time clinical practice where he sees patients with asthma, COPD, bronchiectasis, interstitial lung disease, pulmonary hypertension, lung nodules/masses, and respiratory infections on a daily basis. He also sees patients in the hospital with those diseases plus other patients hospitalized in the intensive care unit (ICU) given his interest in critical care medicine. Dr. Jasmer is board-certified in internal medicine, pulmonary diseases and critical care medicine.
Education & Training
- University of California (San Francisco)Fellowship, Pulmonary Disease and Critical Care Medicine, 1994 - 1997
- Stanford Health Care-Sponsored Stanford UniversityResidency, Internal Medicine, 1990 - 1994
- Washington University in St. Louis School of MedicineClass of 1990
Certifications & Licensure
- CA State Medical License 1991 - 2025
- FL State Medical License 2014 - 2019
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Critical Care Medicine
- American Board of Internal Medicine Pulmonary Disease
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
- Super Doctor SuperDoctors.com
Publications & Presentations
PubMed
- Three months of rifapentine and isoniazid for latent tuberculosis infection.Sterling TR, Villarino ME, Borisov AS, Shang N, Gordin F, Bliven-Sizemore E, Hackman J, Hamilton CD, Menzies D, Kerrigan A, Weis SE, Weiner M, Wing D, Conde MB, Bozema...> ;The New England journal of medicine.
- Effect of HIV infection on tolerability and bacteriologic outcomes of tuberculosis treatment.Bliven-Sizemore EE, Johnson JL, Goldberg S, Burman WJ, Villarino ME, Chaisson RE, Tuberculosis Clinical Trials Consortium> ;The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.
- Treatment for preventing tuberculosis in children and adolescents: a randomized clinical trial of a 3-month, 12-dose regimen of a combination of rifapentine and isonia...Villarino ME, Scott NA, Weis SE, Weiner M, Conde MB, Jones B, Nachman S, Oliveira R, Moro RN, Shang N, Goldberg SV, Sterling TR, International Maternal Pediatric and A...> ;JAMA pediatrics.
- Join now to see all
Press Mentions
- Sulfonylureas, Basal Insulins Tied to Increased CV Risk in T2DDecember 27th, 2018
- Study Pinpoints Factors Tied to Aggressive SCC After TransplantDecember 11th, 2018
- Mastery in Diabetes Management: Acute MI Inpatient Mortality Rate Linked to T1D?August 17th, 2017
- Join now to see all
Grant Support
- Expanding Preventing Therapy For Tuberculous InfectionNational Institute Of Allergy And Infectious Diseases1998–2002
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: